Tag: rassilka2

AbbVie and Morphic Therapeutic to cooperate on antifibrotic medications

AbbVie and Morphic Therapeutic (Massachusetts, USA) announced that the companies have entered into a research and development collaboration designed to advance a number of oral integrin therapeutics.

Amgen invests in Oxford Nanopore and its genetic sequencing technology

Amgen announced investment of $66 million in Oxford Nanopore, a privately-owned, UK-based company advancing a new generation of portable, real-time genetic sequencing technology.